Invesco Nasdaq Biotechnology ETF (IBBQ)

NASDAQ: IBBQ · Real-Time Price · USD

34.41

-0.52 (-1.49%)

Sep 10, 2026, 4:00 PM EDT - Market closed

Assets	$99.76M
Expense Ratio	0.19%
PE Ratio	24.46
Shares Out	2.78M
Dividend (ttm)	$0.26
Dividend Yield	0.75%
Ex-Dividend Date	Jun 22, 2026
Payout Frequency	Quarterly
Payout Ratio	18.25%

Volume	19,847
Open	34.91
Previous Close	34.93
Day's Range	34.41 - 34.91
52-Week Low	23.42
52-Week High	36.84
Beta	0.61
Holdings	259
Inception Date	Jun 11, 2021

About IBBQ

Fund Home Page

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is issued by Invesco.

Asset Class Equity

Category Health

Region North America

Stock Exchange NASDAQ

Ticker Symbol IBBQ

ETF Provider Invesco

Index Tracked NASDAQ / Biotechnology

Top 10 Holdings

44.81% of assets

Name	Symbol	Weight
Amgen Inc.	AMGN	8.77%
Vertex Pharmaceuticals Incorporated	VRTX	8.25%
Gilead Sciences, Inc.	GILD	7.52%
Regeneron Pharmaceuticals, Inc.	REGN	5.46%
Moderna, Inc.	MRNA	3.93%
Revolution Medicines, Inc.	RVMD	2.87%
Alnylam Pharmaceuticals, Inc.	ALNY	2.11%
Biogen Inc.	BIIB	2.05%
Illumina, Inc.	ILMN	2.02%
argenx SE	ARGX	1.82%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Jun 22, 2026	$0.03422	Jun 26, 2026
Mar 23, 2026	$0.03609	Mar 27, 2026
Dec 22, 2025	$0.0906	Dec 26, 2025
Sep 22, 2025	$0.09576	Sep 26, 2025
Jun 23, 2025	$0.0287	Jun 27, 2025
Mar 24, 2025	$0.04021	Mar 28, 2025

Full Dividend History

Performance

IBBQ had a total return of 44.22% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.85%.